Yungjin Pharm. Co., Ltd.
- Country
- 🇰🇷South Korea
- Ownership
- Public, Subsidiary
- Established
- 1962-07-16
- Employees
- 624
- Market Cap
- -
- Website
- http://www.yungjin.co.kr
A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 88
- Registration Number
- NCT04703868
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Daehak-ro Jongno-gu, Korea, Republic of
A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2017-09-07
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 116
- Registration Number
- NCT03275025
- Locations
- 🇰🇷
Kelmyung University Dongsan Medical Center, Daegu, Korea, Republic of
🇰🇷Chungbuk National University Hospital, Chungju, Korea, Republic of
🇰🇷Hanllym University Medical Center, Anyang, Korea, Republic of
Evaluate the Pharmacokinetic Characteristics and Safety/Tolerability of YNP-1807 Compared to Lyrica® After Oral Administration Adult Volunteers
- First Posted Date
- 2017-08-25
- Last Posted Date
- 2019-07-10
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 17
- Registration Number
- NCT03261427
- Locations
- 🇰🇷
Severance Hospital, Seoul, Yonsei-ro Seodaemun-gu, Korea, Republic of
Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers
- First Posted Date
- 2017-02-17
- Last Posted Date
- 2018-04-27
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT03056209
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2017-12-21
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 11
- Registration Number
- NCT02338856
- Locations
- 🇰🇷
Kyungpook National University Hospital, Daegu, Dongduck-ro, Jung-gu, Korea, Republic of
A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients
- Conditions
- Interventions
- First Posted Date
- 2014-10-23
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 61
- Registration Number
- NCT02272634
- Locations
- 🇺🇸
Florida Pulmonary Research Institute, LLC, Winter Park, Florida, United States
🇺🇸Temple Lung Center, Temple University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸UAB Lung Health Center, Birmingham, Alabama, United States
Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
- Conditions
- Interventions
- First Posted Date
- 2014-03-20
- Last Posted Date
- 2017-12-21
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 147
- Registration Number
- NCT02092207
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Irwon-ro, Gangnam-gu, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Gyeonggi-do, Gumi-ro 173 Beon-gil Bundang-gu, Korea, Republic of
🇰🇷Chonnam National University Hospital, Gwangju, Jebong-ro, Dong-gu, Korea, Republic of
Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis
- Conditions
- Interventions
- First Posted Date
- 2014-01-08
- Last Posted Date
- 2017-12-21
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT02029586
- Locations
- 🇰🇷
ASAN Medical Center, Seoul, Olympic-ro 43-gil, Songpa-gu, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Daehak-ro Jongno-gu, Korea, Republic of
🇰🇷Seoul St. Mary's Hospital, Seoul, Banpo-daero Seocho-gu, Korea, Republic of
A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis
- Conditions
- Interventions
- First Posted Date
- 2013-06-27
- Last Posted Date
- 2015-12-22
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 182
- Registration Number
- NCT01888536
- Locations
- 🇰🇷
Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷Inje University Sanggye Paik Hospital, Seoul, Korea, Republic of
🇰🇷KyungHee University Medical Center, Seoul, Korea, Republic of
Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination
- First Posted Date
- 2013-06-18
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- Yungjin Pharm. Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01880125